Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Guideline directed therapy for CRM disease: the evidence base
Author(s): Lars H Lund , Marco Metra , Nikolaus Marx , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Intissar Haddiya, Dr Lars Lund, Prof Marco Metra, Prof Nikolaus Marx, Prof Peter Rossing and Prof Giuseppe Rosano discuss guideline directed therapy for CRM disease. View more

Heart Failure

Prevention & Chronic Conditions
Research Area(s) / Expertise:

Expertise

Heart Failure
Research Area(s) / Expertise:

Expertise

Heart Failure
POTCAST: Raising Potassium Levels Reduces Arrhythmia Risk in ICD Patients
Added: 9 months ago Source:  Arrhythmia Academy
A strategy of actively increasing plasma potassium to high-normal levels significantly lowered the risk of arrhythmia events in high-risk patients with an implantable cardioverter–defibrillator (ICD), according to results from the POTCAST trial.¹˒² The findings were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the New England Journal of… View more

Electrophysiology & Arrhythmia

Heart Failure
Research Area(s) / Expertise:

Expertise

Heart Failure
HFSA 25: Excercise Effects of Aficamten Vs Metoprolol in MAPLE-HCM
Author(s): Gregory Lewis Added: 8 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance… View more

Heart Failure
Research Area(s) / Expertise:

Expertise

Heart Failure
ACC 25: 4 Trials That Will Change My Practice
Author(s): Dipti Itchhaporia Added: 1 year ago
ACC 2025 - In this succinct video, Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute & University of California, CA, US) outlines the key late-breaking trials from the conference that are expected to have an impact on clinical practice.Trials covered in detail include:FRESH-UPAPI-CATALIGN-ARPROTECT-TAVIRecorded on-site at ACC in Chicago, 2025.Support: This is an independent interview… View more

Intervention

Heart Failure
Complete Revascularization in Shock with Dr Tara Jones
Author(s): Tara Jones Added: 8 months ago
Learn about revascularisation strategies in cardiogenic shock after acute MI, including culprit-only vs multivessel PCI, from Dr Tara Jones (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more

Intervention

MI/ACS
Definitions and Implications of Shock Diagnosis and Therapy with Dr Frederick Welt
Author(s): Frederick Welt Added: 8 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more

Intervention

MI/ACS